Evaluation of DNA methylation in BDNF, SLC6A4, NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder

References

• Hardeveld F , SpijkerJ , DeGraaf R , NolenW , BeekmanA. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr. Scand.122(3), 184–191 (2010).
   PubMed Web of Science ®Google Scholar
• Clark SL , HattabMW , ChanRFet al. A methylation study of long-term depression risk. Mol. Psychiatry25(6), 1334–1343 (2020).
   PubMed Web of Science ®Google Scholar
• Frokjaer VG . Pharmacological sex hormone manipulation as a risk model for depression. J. Neurosci. Res.98(7), 1283–1292 (2020).
   PubMed Web of Science ®Google Scholar
• Gharraee B , TajrishiKZ , SheybaniFet al. Prevalence of major depressive disorder in the general population of Iran: a systematic review and meta-analysis. Med. J. Islam. Repub. Iran33, 151 (2019).
   PubMedGoogle Scholar
• Lee M-S . Pharmacogenetic treatment of depressive disordersFuture Neurol.2(3), 329–3382007).
   Google Scholar
• Kraus C , KadriuB , LanzenbergerR , ZarateCA Jr , KasperS. Prognosis and improved outcomes in major depression: a review. Transl. Psychiatry9(1), 127 (2019).
   PubMed Web of Science ®Google Scholar
• Bialek K , CzarnyP , StrycharzJ , SliwinskiT. Major depressive disorders accompanying autoimmune diseases – response to treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry95109678 (2019).
   PubMed Web of Science ®Google Scholar
• Mullins CD , ShayaFT , MengF , WangJ , HarrisonD. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy25(5), 660–667 (2005).
   PubMed Web of Science ®Google Scholar
• Lozupone M , PanzaF. Social determinants of late-life depression epigenetics. Epigenomics12(7), 559–562 (2020).
   PubMed Web of Science ®Google Scholar
• Isbister GK , BoweSJ , DawsonA , WhyteIM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J. Toxicol. Clin. Toxicol.42(3), 277–285 (2004).
   PubMed Web of Science ®Google Scholar
• Narasimhan S , LohoffFW. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions. Pharmacogenomics13(4), 441–464 (2012).
   PubMed Web of Science ®Google Scholar
• Hyttel J ,Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol.9( Suppl. 1),19–26( 1994).
   PubMed Web of Science ®Google Scholar
• Reynolds GP , FachimHA. Does DNA methylation influence the effects of psychiatric drugs?Epigenomics8(3), 309–312 (2016).
   PubMed Web of Science ®Google Scholar
• Tsai S-J , HongC-J , LiouY-J. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics. Pharmacogenomics9(9),1353–1358( 2008).
   PubMed Web of Science ®Google Scholar
• García-Marín LM , RabinowitzJA , CejaZ , AlcauterS , Medina-RiveraA , RenteríaME. The pharmacogenomics of selective serotonin reuptake inhibitors. Pharmacogenomics4, 233–244( 2022).
   Google Scholar
• Czarny P , BiałekK , ZiółkowskaS , StrycharzJ , BarszczewskaG , SliwinskiT. The importance of epigenetics in diagnostics and treatment of major depressive disorder. J. Pers. Med.11(3), 167 (2021).
   PubMed Web of Science ®Google Scholar
• Zhou J , LiM , WangXet al. Drug response-related DNA methylation changes in schizophrenia, bipolar disorder, and major depressive disorder. Front. Neurosci.15, 674273( 2021).
   PubMed Web of Science ®Google Scholar
• Kimmel M , KaminskyZ , PayneJL. Biomarker or pathophysiology? The role of DNA methylation in postpartum depression. Epigenomics5(5), 473–475 (2013).
   PubMed Web of Science ®Google Scholar
• Volkow ND , KoobG , BalerR. Biomarkers in substance use disorders. ACS Chem. Neurosci.6(4), 522–525 (2015).
   PubMed Web of Science ®Google Scholar
• Dereix AE , LedyardR , RedhuntAMet al. Maternal anxiety and depression in pregnancy and DNA methylation of the NR3C1 glucocorticoid receptor gene. Epigenomics13(21), 1701–1709 (2021).
   PubMed Web of Science ®Google Scholar
• Shields AE , WiseLA , Ruiz-NarvaezEAet al. Childhood abuse, promoter methylation of leukocyte NR3C1 and the potential modifying effect of emotional support. Epigenomics8(11), 1507–1517 (2016).
   PubMed Web of Science ®Google Scholar
• Nagarajan S , SeddighzadehB , BaccarelliA , WiseLA , WilliamsM , ShieldsAE. Adverse maternal exposures, methylation of glucocorticoid-related genes and perinatal outcomes: a systematic review. Epigenomics8(7), 925–944 (2016).
   PubMed Web of Science ®Google Scholar
• Winkler BK , LehnertH , OsterH , KirchnerH , HarbeckB. FKBP5 methylation as a possible marker for cortisol state and transient cortisol exposure in healthy human subjects. Epigenomics9(10), 1279–1286 (2017).
   PubMed Web of Science ®Google Scholar
• Montirosso R , ProvenziL , GiordaRet al. SLC6A4 promoter region methylation and socio-emotional stress response in very preterm and full-term infants. Epigenomics8(7), 895–907 (2016).
   PubMed Web of Science ®Google Scholar
• Park C , RosenblatJD , BrietzkeEet al. Stress, epigenetics and depression: a systematic review. Neurosci. Biobehav. Rev.102, 139–152 (2019).
   PubMed Web of Science ®Google Scholar
• Iamjan S-A , ThanoiS , WatiktinkornPet al. Changes of BDNF exon IV DNA methylation are associated with methamphetamine dependence. Epigenomics13(12), 953–965 (2021).
   PubMed Web of Science ®Google Scholar
• Scharinger C , BartovaL , PezawasL. Brain-derived neurotrophic factor: a peripheral biomarker for major depressive disorder and antidepressant efficacy?Per. Med.8(2), 115–117 (2011).
   PubMed Web of Science ®Google Scholar
• Ahmadimanesh M , AbbaszadeganMR , RadDMet al. Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression. J. Psychopharmacol.33(11), 1364–1376 (2019).
   PubMed Web of Science ®Google Scholar
• Switzeny OJ , ChristmannM , RenovanzM , GieseA , SommerC , KainaB. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response. Clin. Epigenetics8(1), 1–10 (2016).
   PubMedGoogle Scholar
• Nourian YH , Beh-PajoohA , AliomraniMet al. Changes in DNA methylation in APOE and ACKR3 genes in multiple sclerosis patients and the relationship with their heavy metal blood levels. Neurotoxicology87, 182–187 (2021).
   PubMed Web of Science ®Google Scholar
• Numakawa T , SuzukiS , KumamaruE , AdachiN , RichardsM , KunugiH. BDNF function and intracellular signaling in neurons. Histol. Histopathol.25, 237–258(2010).
   PubMed Web of Science ®Google Scholar
• Stein DJ , DanielsWM , SavitzJ , HarveyBH. Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology. CNS Spectr.13(11), 945–949 (2008).
   PubMed Web of Science ®Google Scholar
• Castrén E , RantamäkiT. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev. Neurobiol.70(5), 289–297 (2010).
   PubMed Web of Science ®Google Scholar
• Aid T , KazantsevaA , PiirsooM , PalmK , TimmuskT. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res.85(3), 525–535 (2007).
   PubMed Web of Science ®Google Scholar
• Martinowich K , HattoriD , WuHet al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science302(5646), 890–893 (2003).
   PubMed Web of Science ®Google Scholar
• Fuchikami M , MorinobuS , SegawaMet al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLOS ONE6(8), e23881 (2011).
   PubMed Web of Science ®Google Scholar
• Tadić A , Müller-EnglingL , SchlichtKet al. Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol. Psychiatry19(3), 281–283 (2014).
   PubMed Web of Science ®Google Scholar
• Chen D , MengL , PeiF , ZhengY , LengJ. A review of DNA methylation in depression. J. Clin. Neurosci.43, 39–46 (2017).
   PubMed Web of Science ®Google Scholar
• Gassen NC , FriesGR , ZannasASet al. Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Sci. Signal.8(404), ra119 (2015).
   PubMed Web of Science ®Google Scholar
• Melas PA , RogdakiM , LennartssonAet al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int. J. Neuropsychopharmacol.15(5), 669–679 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang Y , GuF , ChenJ , DongW. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res.1366, 141–148 (2010).
   PubMed Web of Science ®Google Scholar
• Russo-Neustadt A , HaT , RamirezR , KesslakJP. Physical activity–antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav. Brain Res.120(1), 87–95 (2001).
   PubMed Web of Science ®Google Scholar
• Turner JD , AltSR , CaoLet al. Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochem. Pharmacol.80(12), 1860–1868 (2010).
   PubMed Web of Science ®Google Scholar
• Murgatroyd C , QuinnJ , SharpH , PicklesA , HillJ. Effects of prenatal and postnatal depression, and maternal stroking, at the glucocorticoid receptor gene. Transl. Psychiatry5(5), e560 (2015).
   PubMedGoogle Scholar
• Oberlander TF , WeinbergJ , PapsdorfM , GrunauR , MisriS , DevlinAM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics3(2), 97–106 (2008).
   PubMed Web of Science ®Google Scholar
• Luddington NS , MandadapuA , HuskM , El-MallakhRS. Clinical implications of genetic variation in the serotonin transporter promoter region: a review. Prim. Care Companion J. Clin. Psychiatry11(3), 93 (2009).
   PubMedGoogle Scholar
• Webb LM , PhillipsKE , HoMC , VeldicM , BlackerCJ. The relationship between DNA methylation and antidepressant medications: a systematic review. Int. J. Mol. Sci.21(3), 826 (2020).
   PubMed Web of Science ®Google Scholar
• Philibert R , MadanA , AndersenA , CadoretR , PackerH , SandhuH. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(1), 101–105 (2007).
   Google Scholar
• Olsson C , FoleyD , Parkinson-BatesMet al. Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biol. Psychol.83(2), 159–165 (2010).
   PubMed Web of Science ®Google Scholar
• Gaspar P , CasesO , MaroteauxL. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci.4(12), 1002–1012 (2003).
   PubMed Web of Science ®Google Scholar
• Schiele MA , ZwanzgerP , SchwarteK , AroltV , BauneBT , DomschkeK. Serotonin transporter gene promoter hypomethylation as a predictor of antidepressant treatment response in major depression: a replication study. Int. J. Neuropsychopharmacol.24(3), 191–199 (2021).
   PubMed Web of Science ®Google Scholar
• Wang Q , SheltonRC , DwivediY. Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: a systematic review and meta-analysis. J. Affect. Disord.225, 422–428 (2018).
   PubMed Web of Science ®Google Scholar
• Zannas AS , WiechmannT , GassenNC , BinderEB. Gene–stress–epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology41(1), 261–274 (2016).
   PubMed Web of Science ®Google Scholar
• Höhne N , PoidingerM , MerzFet al. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. Int. J. Neuropsychopharmacol.18(4), pyu087 (2015).
   Web of Science ®Google Scholar
• Weder N , ZhangH , JensenKet al. Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry. J. Am. Acad. Child Adolesc. Psychiatry53(4), 417–424.e5 (2014).
   PubMed Web of Science ®Google Scholar
• Klinger-König J , HertelJ , Vander Auwera Set al. Methylation of the FKBP5 gene in association with FKBP5 genotypes, childhood maltreatment and depression. Neuropsychopharmacology44(5), 930–938 (2019).
   PubMed Web of Science ®Google Scholar
• Miller O , Shakespeare-FinchJ , BruenigD , MehtaD. DNA methylation of NR3C1 and FKBP5 is associated with posttraumatic stress disorder, posttraumatic growth, and resilience. Psychol. Trauma12(7), 750 (2020).
   PubMed Web of Science ®Google Scholar
• Matosin N , HalldorsdottirT , BinderEB. Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: the FKBP5 model. Biol. Psychiatry83(10), 821–830 (2018).
   PubMed Web of Science ®Google Scholar
• Yehuda R , DaskalakisNP , DesarnaudFet al. Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD. Front. Psychiatry4(118), (2013).
   PubMedGoogle Scholar
• Lopez J , MamdaniF , LabonteBet al. Epigenetic regulation of BDNF expression according to antidepressant response. Mol. Psychiatry18(4), 398–399 (2013).
   PubMed Web of Science ®Google Scholar
• Okada S , MorinobuS , FuchikamiMet al. The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression. J. Psychiatr. Res.53, 47–53 (2014).
   PubMed Web of Science ®Google Scholar